ASB7: A Protein Regulating Tissue Development and Disease (G140460)

Target Name: ASB7

NCBI ID: G140460

ASB7

ASB7: A Protein Regulating Tissue Development and Disease

ASB7 (ASB7_HUMAN) is a protein that is expressed in various tissues of the human body. It is a member of the Asparagine/Glutamyl Proteine (ASP/ASG) family and is characterized by a unique N-terminus that consists of a long sequence of amino acids known as the Asparagine- Glutamyl- Aspartate (ASP-Glu-ASP) repeat.

ASB7 is involved in a variety of cellular processes, including cell signaling, cell adhesion, and tissue repair. It is a key regulator of the Wnt signaling pathway, which is a critical pathway involved in the development and maintenance of tissues during embryonic development and throughout life.

ASB7 has also been shown to play a role in the regulation of cell proliferation, and is a negative regulator of the T-cell receptor (TCR), which is a key regulator of adaptive immunity.

ASB7 is also a potential drug target, as it has been shown to be involved in a variety of cellular processes that are associated with the development and treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

One of the key features of ASB7 is its ability to interact with a variety of different molecules, including tyrosines, which are proteins that play a key role in the regulation of cellular processes and are involved in the development of many diseases.

ASB7 can interact with tyrosines located on the surface of cells, as well as within the cells themselves. This interaction with tyrosines allows ASB7 to regulate the activity of these molecules and to play a role in the development of various diseases.

In addition to its role in the regulation of tyrosines, ASB7 is also involved in the regulation of the Wnt signaling pathway. This pathway is involved in the development and maintenance of tissues during embryonic development and throughout life, and is a key regulator of many diseases, including cancer.

ASB7 is a key regulator of the Wnt signaling pathway, and its activity in this pathway has been shown to be involved in the development and maintenance of tissues during embryonic development and throughout life. This includes the regulation of cell proliferation and the development of tissues such as the nervous system and the cardiovascular system.

ASB7 is also involved in the regulation of the T-cell receptor (TCR), which is a key regulator of adaptive immunity. This includes the regulation of T-cell proliferation and the development of T-cells, which are responsible for many important functions of the immune system, including the regulation of infections and the elimination of cancer cells.

ASB7 is also involved in the regulation of the production of matrix proteins, which are proteins that are involved in the structure and function of tissues. This includes the regulation of the production of extracellular matrix (ECM) proteins, which are involved in the regulation of cell migration and the development of tissues.

In addition to its role in the regulation of cellular processes, ASB7 is also involved in the regulation of many different diseases. For example, it has been shown to be involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

ASB7 is also involved in the regulation of the development and progression of cancer, including the regulation of the growth and survival of cancer cells. This includes the regulation of cell proliferation and the development of tumors, as well as the regulation of the metastasis of cancer cells.

In addition to its role in the regulation of cellular processes, ASB7 is also involved in the regulation of many different diseases. For example, it has been shown to be involved in

Protein Name: Ankyrin Repeat And SOCS Box Containing 7

Functions: Probable substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins

The "ASB7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ASB7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets